Integra Lifesciences Holdings (IART) Debt Ratio (2009 - 2026)

Integra Lifesciences Holdings has disclosed Debt Ratio across 18 years of filings, most recently posting 0.5 for Q2 2026.

• In Q2 2026, Debt Ratio rose 8.22% year-over-year to 0.5; the TTM figure through Jun 2026 stood at 0.5 (up 8.22% YoY), while the FY2025 annual figure was 0.5, up 22.63% from the prior year.
• Debt Ratio came in at 0.5 for Q2 2026 at Integra Lifesciences Holdings, roughly flat from 0.5 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.5 in Q4 2025 to a low of 0.22 in Q4 2022.
• Average Debt Ratio over 5 years is 0.35, with a median of 0.31 recorded in 2024.
• Year-over-year, Debt Ratio declined 13.03% in 2022 and soared 70.1% in 2024.
• Over 5 years, Debt Ratio stood at 0.22 in 2022, then gained by 12.29% to 0.24 in 2023, then soared by 70.1% to 0.41 in 2024, then gained by 22.63% to 0.5 in 2025, then decreased by 1.01% to 0.5 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.5 in Q2 2026, 0.5 in Q1 2026, and 0.5 in Q4 2025.